A study by Yang et al. [19] found that Nrf2 expression predicted chemo-resistance and tumor progression in NSCLC patients, whereas Prx1 rather than Nrf2 was considered the independent prognostic factor in another study [17]. The gene discussed is NFE2L2; the disease is non-small cell lung carcinoma.